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Helpless without SAP
CD4+ T cells that lack the adaptor protein SAP are little help 
to B cells, according to Cannons and colleagues on page 1551. 
But their unhelpful nature does not result from a failure to 
produce T helper (Th)-2 cytokines, as the authors had 
previously thought.
The absence of SAP wreaks havoc on the immune system. 
SAP—the adaptor that links the SLAM family of activating 
receptors to the downstream signaling protein Fyn—is ex-
pressed in most immune cell types and its absence causes a 
bevy of immune defects.
Mutations in SAP cause a rare disease called X-linked 
lymphoproliferative disease (XLP), which is characterized in 
part by extreme susceptibility to Epstein Barr virus (EBV) 
infection. Those who survive EBV infection often have long-
term antibody deficiencies. But Cannons and colleagues put 
the blame for this not on B cells, but on CD4+ T cells.
Previous studies in SAP-deficient mice revealed defects 
in both CD4+ T cells and B cells. But whether one cell type 
is mostly to blame for the glitch in antibody production has 
been controversial. Here, Cannons and colleagues put the 
rap squarely on the CD4+ T cells, as transfer of wild-type 
T cells into SAP-deficient mice restored immunization-
induced antibody production, even when the B cells still 
lacked the adaptor.
The authors suspected 
(based on previous work with 
SAP-deficient T cells) that 
SAP-deficient mice might be 
unable to secrete antibody-
promoting Th2 cytokines, such 
as interleukin (IL)-4 and IL-10. 
But when they infected the 
mice with Shistosoma mansonii 
eggs—a classic Th2 trigger—
the mice had no problem 
producing these cytokines. 
Antibody production, on the 
other hand, was still blocked.
The antibody defect was instead traced to changes in the 
expression of two T cell costimulatory molecules: CD40 ligand 
(CD40L) and ICOS. In SAP-deficient cells, CD40L expression 
was increased and ICOS expression was decreased—both 
changes that have been shown to inhibit antibody production. 
A decrease in ICOS expression has also been reported on 
T cells from patients with XLP.
SAP’s ability to bind Fyn was dispensable for antibody 
production, as T cells containing a Fyn binding mutant of 
SAP still restored antibody production in mutant mice. The 
authors are now characterizing this previously unrecognized 
signaling pathway. 
The bacterium Anaplasma phagocytophilum 
uses a tick protein to help it set up camp 
in the insect’s salivary glands, according to 
Sukumaran and colleagues (page 1507).
Many tick-borne pathogens hijack 
host proteins to establish infection in 
their tick vector or mammalian host. 
Previous work by this group, for 
example, showed that the Lyme disease 
bacterium Borrelia burgdorferi induces 
the expression of the salivary protein 
Salp15 in infected Ixodes scapularis 
ticks as they feed. The bacterium then 
coats itself with Salp15 as it exits the 
tick, creating a shield against the 
destructive antibodies encountered in 
the mammalian host.
Here, Sukumaran and colleagues used 
a similar approach to study the obligate 
intracellular bacterium A. phagocytophilum, 
which causes a common and sometimes 
deadly tick-borne disease in humans called 
anaplasmosis (formerly granulocytic 
ehrlichiosis). They found that if I. scapularis 
ticks fed on A. phagocytophilum–infected 
mice, the ticks selectively increased their 
expression of the salivary protein Salp16.
But in this case, Salp16 was used for 
protection in the tick, not the 
mammalian host. Inhibiting Salp16 
expression in the tick (using RNAi) 
reduced the number of bacteria in the 
insect’s salivary glands, suggesting that 
Salp16 was needed for the bacterium to 
establish a foothold in the salivary gland 
where it resides after migrating from the 
gut. Once there, however, the bug no 
longer required Salp16 to maintain its 
residence. Inhibiting Salp16 had no 
effect on transmission of the bug to the 
mouse reservoir or on the initial uptake 
of the bug (with the blood meal) into 
the tick gut.
The authors are now trying to 
determine how Salp16 helps A. 
phagocytophilum to colonize the salivary 
gland. In the meantime, blocking Salp16 in 
ticks might provide a way to disrupt the 
transmission cycle of the pathogen and 
thus lower the prevalence of disease. 
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Wild-type CD4+ T cells (black 
circles), but not SAP-deficient 
CD4+ T cells (closed squares), 
restore antibody production in 
SAP-deficient mice.